DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,978 filers reported holding DANAHER CORPORATION in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $685,797,171 | +2.1% | 3,118,488 | +11.5% | 0.24% | +4.0% |
Q2 2023 | $671,406,960 | -3.5% | 2,797,529 | +1.3% | 0.23% | -11.0% |
Q1 2023 | $695,925,034 | -22.4% | 2,761,169 | -18.3% | 0.26% | -23.7% |
Q4 2022 | $897,151,184 | +21.9% | 3,380,119 | +18.7% | 0.33% | +3.7% |
Q3 2022 | $735,747,000 | -0.3% | 2,848,535 | -2.2% | 0.32% | +6.3% |
Q2 2022 | $738,141,000 | -21.4% | 2,911,569 | -9.1% | 0.30% | -2.9% |
Q1 2022 | $939,160,000 | -7.1% | 3,201,724 | +4.2% | 0.31% | +7.6% |
Q4 2021 | $1,010,924,000 | +10.7% | 3,072,627 | +2.4% | 0.29% | +1.0% |
Q3 2021 | $913,603,000 | -4.7% | 3,000,934 | -16.0% | 0.29% | -7.1% |
Q2 2021 | $959,159,000 | +22.4% | 3,574,150 | +2.7% | 0.31% | +18.4% |
Q1 2021 | $783,470,000 | -2.4% | 3,480,853 | -3.6% | 0.26% | -3.7% |
Q4 2020 | $802,449,000 | -2.1% | 3,612,357 | -5.1% | 0.27% | -12.3% |
Q3 2020 | $819,384,000 | +13.6% | 3,805,243 | -6.7% | 0.31% | +1.6% |
Q2 2020 | $721,021,000 | +6.8% | 4,077,479 | -16.4% | 0.30% | -4.4% |
Q1 2020 | $675,087,000 | -19.6% | 4,877,428 | -10.9% | 0.32% | +8.9% |
Q4 2019 | $839,899,000 | +1.6% | 5,472,367 | -4.4% | 0.29% | -8.2% |
Q3 2019 | $826,829,000 | +2.5% | 5,724,776 | +1.5% | 0.32% | +2.3% |
Q2 2019 | $806,415,000 | -3.1% | 5,642,414 | -10.4% | 0.31% | -9.6% |
Q1 2019 | $831,830,000 | +39.9% | 6,300,787 | +9.2% | 0.34% | +27.9% |
Q4 2018 | $594,770,000 | -4.3% | 5,767,744 | +0.9% | 0.27% | +9.3% |
Q3 2018 | $621,420,000 | +35.5% | 5,718,929 | +23.1% | 0.25% | +23.6% |
Q2 2018 | $458,480,000 | +4.1% | 4,646,132 | +3.3% | 0.20% | +4.7% |
Q1 2018 | $440,476,000 | +4.8% | 4,498,789 | -0.6% | 0.19% | +10.5% |
Q4 2017 | $420,303,000 | +9.1% | 4,528,152 | +0.8% | 0.17% | -3.4% |
Q3 2017 | $385,224,000 | -4.5% | 4,490,834 | -6.0% | 0.18% | -14.4% |
Q2 2017 | $403,248,000 | +1.1% | 4,778,393 | +2.5% | 0.21% | -4.1% |
Q1 2017 | $398,715,000 | +17.2% | 4,661,695 | +6.7% | 0.22% | +15.4% |
Q4 2016 | $340,233,000 | +6.0% | 4,370,927 | +6.7% | 0.19% | -1.6% |
Q3 2016 | $321,025,000 | -15.4% | 4,095,226 | +9.0% | 0.19% | -20.1% |
Q2 2016 | $379,510,000 | +11.0% | 3,757,519 | +4.3% | 0.24% | +4.4% |
Q1 2016 | $341,836,000 | +7.7% | 3,603,582 | +5.5% | 0.23% | +11.2% |
Q4 2015 | $317,360,000 | +25.7% | 3,416,887 | +15.3% | 0.21% | +15.7% |
Q3 2015 | $252,429,000 | +6.1% | 2,962,430 | +6.6% | 0.18% | +12.7% |
Q2 2015 | $237,871,000 | +24.2% | 2,779,185 | +23.1% | 0.16% | +18.8% |
Q1 2015 | $191,599,000 | -1.4% | 2,256,761 | -0.4% | 0.13% | -1.5% |
Q4 2014 | $194,233,000 | – | 2,266,174 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |